Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BXRXV - Baudax Bio Inc

Close
4.48
-0.030   -0.670%

Share volume: 583,718
Last Updated: Fri 22 Nov 2019 10:00:00 PM CET
Pharmaceuticals: Major: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$4.51
-0.03
-0.67%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
59%
Profitability 75%
Dept financing 25%
Liquidity 25%
Performance 60%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$4.48
P/E Ratio 
N/A
DAY RANGE
$3.60 - $4.84
EPS 
$0.00
52 WEEK RANGE
$3.60 - $9.00
52 WEEK CHANGE
-$36.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$121,979
AVERAGE 30 VOLUME 
$121,979
Company detail
CEO: Gerri A. Henwood
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Pharmaceuticals: Major
Sector: Health Technology

Baudax Bio, Inc. is a pharmaceutical company focusing on developing and commercializing products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.

Recent news